abstract |
The present invention relates to pyrimidine compounds of the formula I, their use as medicaments for the treatment of diseases that are induced, or their severity, by the overproduction of prostaglandin E, which are inflammatory and tumor diseases, and the pharmaceutical composition containing them. |